A multi-centre, stratified, open, randomized, comparator-controlled, parallel group phase II trial comparing adjuvant treatment with 177Lu-DOTATATE to standard of care in patients after resection of neuroendocrine liver metastases (NELMAS).

Authors: Andreja Frilling, Richard P. Baum, Kirill Veselkov, Elena Ferrer Martinez Del Peral, Maria Martinez, Marcos Lovelle, Jiwen Wu, Son-Mi Park, Ashley Clift, Amy Eccles, James Hubber, Harpreet Singh Wasan, Irvin Mark Modlin

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps4225

Source: Full article

---

Abstract

TPS4225